Endo International has acquired a broad portfolio of branded and generic injectable and established products focused on pain, anti-infectives, cardiovascular and other specialty therapeutics areas from a subsidiary of Aspen Holdings, a publicly-traded South African company that supplies branded and generic products in more than 150 countries. The transaction is expected to expand Endo’s presence in South Africa by adding a product portfolio that generated approximately $28 million last year as w...